Last reviewed · How we verify
AA
Radiation therapy is a treatment that uses high doses of radiation to kill cancer cells.
Radiation therapy is a treatment that uses high doses of radiation to kill cancer cells. Used for Cancer treatment.
At a glance
| Generic name | AA |
|---|---|
| Also known as | flutamide, bicalutamide |
| Sponsor | Radiation Therapy Oncology Group |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | FDA-approved |
Mechanism of action
Radiation therapy works by damaging the DNA of cancer cells, which prevents them from growing and dividing. This can be achieved through external beam radiation therapy, where a machine directs radiation beams at the tumor, or through internal radiation therapy, where a small amount of radioactive material is placed inside the body near the tumor.
Approved indications
- Cancer treatment
Common side effects
- Fatigue
- Nausea
- Diarrhea
Key clinical trials
- ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors (PHASE1, PHASE2)
- Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
- A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer (PHASE2)
- M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501) (PHASE1)
- The Diagnostic Cut-off Value of Core Biomarkers of Alzheimer's Disease
- Detection of Alzheimer's Disease (AD)-Related Seeds for AD Diagnosis
- Study on Biomarkers for Early Diagnosis of Alzheimer's Disease
- A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AA CI brief — competitive landscape report
- AA updates RSS · CI watch RSS
- Radiation Therapy Oncology Group portfolio CI